Close Menu

Creative commons licensing is in the air -- or at least in the blogosphere. A few blogs have written about licensing data or even your genome recently. Deepak Singh at BBGM contends that all "data needs to be licensed in some form, even if it’s open," though he acknowledges that while licensing data from papers is pretty straightforward, he's not sure how scientists would deal with the source data, such as "intensities from a microarray experiment."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.